SCOPUS 정보 검색 플랫폼

Volumn 40, Issue 7, 2011, Pages 1000-1005

Validation of Neurokinin A assays in the United States and Europe

(9) Mamikunian, Paris a Ardill, Joy E b O'Dorisio, Thomas M c Krutzik, Siegfried R a Vinik, Aaron I d Go, Vay Liang W e Armstrong, Lee b Mamikunian, Gregg a Woltering, Eugene A f

a Inter Science Institute (United States)

b ROYAL VICTORIA HOSPITAL (United Kingdom)

c UNIVERSITY OF IOWA (United States)

d EASTERN VIRGINIA MEDICAL SCHOOL (United States)

e UNIVERSITY OF CALIFORNIA (United States)

f LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

biomarkers; carcinoid; clinical study; midgut; neuroendocrine tumors; prognosis

Indexed keywords

NEUROKININ A;

ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; UNITED KINGDOM; UNITED STATES;

CALIBRATION; CLINICAL LABORATORY TECHNIQUES; HUMANS; KAPLAN-MEIER ESTIMATE; NEUROENDOCRINE TUMORS; NEUROKININ A; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOIMMUNOASSAY; REFERENCE STANDARDS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TUMOR MARKERS, BIOLOGICAL;

EID: 80053048707 PISSN: 08853177 EISSN: 15364828 Source Type: Journal
DOI: 10.1097/MPA.0b013e318232b6a2 Document Type: Article

Times cited : (10)

References (9)

1
- 70350647326
- Biochemical testing for neuroendocrine tumors [published correction appears in Pancreas. 2010;39:117]
- Vinik A, Silva MP, Woltering EA, et al. Biochemical testing for neuroendocrine tumors [published correction appears in Pancreas. 2010;39:117]. Pancreas. 2009;38:876-889.
- (2009) Pancreas. , vol.38 , pp. 876-889
- Vinik, A.¹ Silva, M.P.² Woltering, E.A.³

2
- 0346457248
- The importance of the measurement of circulating markers in patients with neuroendocrine tumours of the pancreas and gut
- DOI 10.1677/erc.0.0100459
- Ardill JES, Eriksson B. The importance of the measurement of circulating markers in patients with neuroendocrine tumours of the pancreas and gut. Endocr Relat Cancer. 2003;10:459-462. (Pubitemid 38094882)
- (2003) Endocrine-Related Cancer , vol.10 , Issue.4 , pp. 459-462
- Ardill, J.E.S.¹ Erikkson, B.²

3
- 55949130646
- Gut hormones: Peptide biomarkers for neuroendocrine tumours of the gastro-entero-pancreatic tract [review]
- Ardill JES. Gut hormones: Peptide biomarkers for neuroendocrine tumours of the gastro-entero-pancreatic tract [review]. Ann Clin Biochem. 2008;45:539-559.
- (2008) Ann Clin Biochem. , vol.45 , pp. 539-559
- Ardill, J.E.S.¹

4
- 33749154697
- Validation of serum versus plasma measurements of chromogranin A levels in patients with carcinoid tumors: Lack of correlation between absolute chromogranin A levels and symptom frequency
- DOI 10.1097/01.mpa.0000235302.73615.d4, PII 0000667620061000000007
- Woltering EA, Hilton RS, Zolfoghary CM, et al. Validation of serum versus plasma measurements of chromogranin A levels in patients with carcinoid tumors: Lack of correlation between absolute chromogranin A levels and symptom frequency. Pancreas. 2006;33:250-254. (Pubitemid 44470140)
- (2006) Pancreas , vol.33 , Issue.3 , pp. 250-254
- Woltering, E.A.¹ Hilton, R.S.² Zolfoghary, C.M.³ Thomson, J.⁴ Zietz, S.⁵ Go, V.L.W.⁶ Vinik, A.I.⁷ Vinik, E.⁸ O'Dorisio, T.M.⁹ Mamikunian, G.¹⁰

5
- 77954099329
- Development of a highly sensitive and specific carboxy-terminal human pancreastatin assay to monitor neuroendocrine tumor behavior
- O'Dorisio TM, Krutzik SR, Woltering EA, et al. Development of a highly sensitive and specific carboxy-terminal human pancreastatin assay to monitor neuroendocrine tumor behavior. Pancreas. 2010;39:611-616.
- (2010) Pancreas. , vol.39 , pp. 611-616
- O'Dorisio, T.M.¹ Krutzik, S.R.² Woltering, E.A.³

6
- 55949102682
- A rapid rise in circulating pancreastatin in response to somatostatin analogue therapy is associated with poor survival in patients with neuroendocrine tumours
- Stronge RL, Turner GB, Johnston BT, et al. A rapid rise in circulating pancreastatin in response to somatostatin analogue therapy is associated with poor survival in patients with neuroendocrine tumours. Ann Clin Biochem. 2008;45:560-566.
- (2008) Ann Clin Biochem. , vol.45 , pp. 560-566
- Stronge, R.L.¹ Turner, G.B.² Johnston, B.T.³

7
- 33750296895
- Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours
- DOI 10.1136/gut.2006.092320
- Turner GB, Johnston BT, McCance DR, et al. Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours. Gut. 2006;55:1586-1591. (Pubitemid 44629208)
- (2006) Gut , vol.55 , Issue.11 , pp. 1586-1591
- Turner, G.B.¹ Johnston, B.T.² McCance, D.R.³ McGinty, A.⁴ Watson, R.G.P.⁵ Patterson, C.C.⁶ Ardill, J.E.S.⁷

8
- 80052984764
- Survival data and chromogranin A measurements in patients with midgut carcinoid treated to address tumour bulk, clinical symptoms and rising neurokinin A [abstract P177]
- Ardill JES, Armstrong L, Johnston BT, et al. Survival data and chromogranin A measurements in patients with midgut carcinoid treated to address tumour bulk, clinical symptoms and rising neurokinin A [abstract P177]. Hormones Int J Endocrinol Metab. 2006;5(1):112.
- (2006) Hormones Int J Endocrinol Metab. , vol.5 , Issue.1 , pp. 112
- Ardill, J.E.S.¹ Armstrong, L.² Johnston, B.T.³

9
- 53249142651
- Tachykinins in endocrine tumors and the carcinoid syndrome
- Cunningham JL, Janson ET, Agarwal S, et al. Tachykinins in endocrine tumors and the carcinoid syndrome. Eur J Endocrinol. 2008;159:275-282.
- (2008) Eur J Endocrinol. , vol.159 , pp. 275-282
- Cunningham, J.L.¹ Janson, E.T.² Agarwal, S.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.